Cargando…

Phosphodiesterase 4A confers resistance to PGE2‐mediated suppression in CD25(+)/CD54(+) NK cells

Inadequate persistence of tumor‐infiltrating natural killer (NK) cells is associated with poor prognosis in cancer patients. The solid tumor microenvironment is characterized by the presence of immunosuppressive factors, including prostaglandin E2 (PGE2), that limit NK cell persistence. Here, we inv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Ziqing, Yang, Ying, Neo, Shi Y, Shi, Hao, Chen, Yi, Wagner, Arnika K, Larsson, Karin, Tong, Le, Jakobsson, Per‐Johan, Alici, Evren, Wu, Jing, Cao, Yihai, Wang, Kai, Liu, Lisa L, Mao, Yumeng, Sarhan, Dhifaf, Lundqvist, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926252/ https://www.ncbi.nlm.nih.gov/pubmed/33480074 http://dx.doi.org/10.15252/embr.202051329

Ejemplares similares

Tumor MHC class I expression alters cancer-associated myelopoiesis driven by host NK cells
por: Neo, Shi Yong, et al.
Publicado: (2022)

CD25(bright) NK cells display superior function and metabolic activity under regulatory T cell-mediated suppression
por: Chen, Ziqing, et al.
Publicado: (2023)

Independent control of natural killer cell responsiveness and homeostasis at steady-state by CD11c+ dendritic cells
por: Luu, Thuy Thanh, et al.
Publicado: (2016)

Renal cell carcinoma escapes NK cell‐mediated immune surveillance through the downregulation of DNAM‐1
por: Tong, Le, et al.
Publicado: (2023)

Opposing consequences of signaling through EGF family members: Escape from CTLs could be a bait for NK cells
por: Kiessling, Rolf, et al.
Publicado: (2012)

Inhibiton of tumor-derived prostaglandin-e2 prevents the induction of human myeloid-derived suppressor cells (MDSCs) and rescues anti-tumor immunity
por: Mao, Yumeng, et al.
Publicado: (2014)

Infectious complications and NK cell depletion following daratumumab treatment of Multiple Myeloma
por: Nahi, Hareth, et al.
Publicado: (2019)

Engineered NK Cells Against Cancer and Their Potential Applications Beyond
por: Karvouni, Maria, et al.
Publicado: (2022)

Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity
por: Dahlberg, Carin I. M., et al.
Publicado: (2015)

Regulation of TRAIL-Receptor Expression by the Ubiquitin-Proteasome System
por: Sarhan, Dhifaf, et al.
Publicado: (2014)

Expression of CD226 is associated to but not required for NK cell education
por: Wagner, Arnika K., et al.
Publicado: (2017)

Generation of NK cells with chimeric-switch receptors to overcome PD1-mediated inhibition in cancer immunotherapy
por: Susek, Katharina H., et al.
Publicado: (2022)

Strategies to Augment Natural Killer (NK) Cell Activity against Solid Tumors
por: Chen, Ziqing, et al.
Publicado: (2019)

Reduction of the CD16(−)CD56(bright) NK Cell Subset Precedes NK Cell Dysfunction in Prostate Cancer
por: Koo, Kyo Chul, et al.
Publicado: (2013)

Increased Circulating of CD54(high)CD181(low) Neutrophils in Myelodysplastic Syndrome
por: Yang, Liyan, et al.
Publicado: (2021)

Divergent roles of prostacyclin and PGE(2) in human tendinopathy
por: Bergqvist, Filip, et al.
Publicado: (2019)

ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18)
Publicado: (1990)

MPGES-1-derived PGE2 suppresses CD80 expression on tumor-associated phagocytes to inhibit anti-tumor immune responses in breast cancer
por: Olesch, Catherine, et al.
Publicado: (2015)

Prognostic value of CD133(+) CD54(+) CD44(+) circulating tumor cells in colorectal cancer with liver metastasis
por: Fang, Chao, et al.
Publicado: (2017)

A YAP/TAZ-CD54 axis is required for CXCR2(−)CD44(−) tumor-specific neutrophils to suppress gastric cancer
por: Nie, Pingping, et al.
Publicado: (2022)

Autologous NK cells as consolidation therapy following stem cell transplantation in multiple myeloma
por: Nahi, Hareth, et al.
Publicado: (2022)

Increased Activity of a NK-Specific CAR-NK Framework Targeting CD3 and CD5 for T-Cell Leukemias
por: Voynova, Elisaveta, et al.
Publicado: (2022)

CD38(+)CD39(+) NK cells associate with HIV disease progression and negatively regulate T cell proliferation
por: Qian, Shi, et al.
Publicado: (2022)

Editorial: NK-Myeloid Cell Interactions in the Tumor Microenvironment: Implications for Cancer Immunotherapy
por: Wennerberg, Erik, et al.
Publicado: (2021)

CD163+ immune cell infiltrates and presence of CD54+ microvessels are prognostic markers for patients with embryonal rhabdomyosarcoma
por: Kather, Jakob Nikolas, et al.
Publicado: (2019)

Targeting CD147 for T to NK Lineage Reprogramming and Tumor Therapy
por: Geng, Jie-Jie, et al.
Publicado: (2017)

CD133(+)CD54(+)CD44(+) circulating tumor cells as a biomarker of treatment selection and liver metastasis in patients with colorectal cancer
por: Fang, Chao, et al.
Publicado: (2016)

Non-classical HLA-E restricted CMV 15-mer peptides are recognized by adaptive NK cells and induce memory responses
por: Martín Almazán, Nerea, et al.
Publicado: (2023)

Comprehensive Analyses of Type 1 Diabetes Ketosis- or Ketoacidosis-Related Genes in Activated CD56(+)CD16(+) NK Cells
por: Shi, Ruifeng, et al.
Publicado: (2021)

The Increased Ratio of Blood CD56(bright) NK to CD56(dim) NK Is a Distinguishing Feature of Primary Sjögren's Syndrome
por: Ming, Bingxia, et al.
Publicado: (2020)

TREM2 promotes natural killer cell development in CD3(−)CD122(+)NK1.1(+) pNK cells
por: Lee, Hwa-Youn, et al.
Publicado: (2021)

CD11b(−)CD27(−) NK Cells Are Associated with the Progression of Lung Carcinoma
por: Jin, Jing, et al.
Publicado: (2013)

Effect of Interleukin-15 on CD11b, CD54, and CD62L Expression on Natural Killer Cell and Natural Killer T-Like Cells in Systemic Lupus Erythematosus
por: Lin, Syh-Jae, et al.
Publicado: (2016)

Cross-linking of CD80 and CD86 Diminishes Expression of CD54 on EBV-transformed B Cells through Inactivation of RhoA and Ras
por: Park, Ga Bin, et al.
Publicado: (2011)

CD24+CD44+CD54+EpCAM+ gastric cancer stem cells predict tumor progression and metastasis: clinical and experimental evidence
por: Gómez-Gallegos, Angel A., et al.
Publicado: (2023)

Comparative evaluation of involved free light chain and monoclonal spike as markers for progression from monoclonal gammopathy of undetermined significance to multiple myeloma
por: Gran, Charlotte, et al.
Publicado: (2020)

PGE(1) stimulation of HEK293 cells generates multiple contiguous domains with different [cAMP]: role of compartmentalized phosphodiesterases
por: Terrin, Anna, et al.
Publicado: (2006)

Agonist-specific desensitization of PGE(2)-stimulated cAMP signaling due to upregulated phosphodiesterase expression in human lung fibroblasts
por: Nunez, Francisco J., et al.
Publicado: (2019)

Evolution of a CD3(+)/CD(+) α/ β T-Cell Receptor(+) Mature T-Cell Clone from CD3(-)CD7(+) Sorted Human Bone Marrow Cells
por: Pohla, Heike, et al.
Publicado: (1993)

Porcine NK Cells Stimulate Proliferation of Pseudorabies Virus-Experienced CD8(+) and CD4(+)CD8(+) T Cells
por: De Pelsmaeker, Steffi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ouaou2u9r34ahma4utaur1sg9a